Recommended amount output system, recommended amount output method and program

The system addresses the challenge of uniform equol intake recommendations by using user-specific data to tailor equol and isoflavone intake amounts, enhancing user-specific equol production and symptom management.

JP7580647B1Active Publication Date: 2024-11-11DAICEL CORP
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024068601
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-04-19
Publication Date
2024-11-11
Estimated Expiration
2044-04-19

AI Technical Summary

Technical Problem

Existing systems fail to provide personalized recommendations for equol intake amounts due to varying individual intestinal environments, leading to uniform intake suggestions that are not tailored to each user's equol production ability.

Method used

A system that determines an index value representing equol production ability and user condition, using data from similar users to recommend tailored intake amounts of equol and isoflavones, adjusting based on user feedback and condition improvement.

Benefits of technology

Enables personalized equol intake recommendations, improving individual user outcomes by considering user-specific intestinal environments and symptom responses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007580647000001_ABST
    Figure 0007580647000001_ABST
Patent Text Reader

Abstract

To provide a technology for improving an individual user's equol intake. [Solution] The recommended amount output system includes one or more computers that perform the following steps: acquire an index value representing the level of the target user's equol production ability and information representing the target user's condition; use information of other users, including index values ​​representing the level of other users' equol production ability, information representing the other users' condition, and information representing the other users' equol and / or isoflavone intake, which has been pre-stored in a storage device, to determine a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of other users whose information representing equol production ability and condition is similar to that of the target user; and output the determined recommended amount.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a recommended amount output system, a recommended amount output method, and a program. [Background technology]

[0002] Conventionally, a system has been proposed that proposes a list of foods that will supplement the nutrients that a user is lacking (for example, Patent Document 1). In this system, the amount of excess or deficiency of nutrients consumed by the user is transmitted from a mobile terminal to a product proposal server. Depending on the received nutrient excess or deficiency information, the product proposal server refers to a product database that stores the names of products that supplement various nutrients, and returns information about products that the user should consume to the mobile terminal. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] JP 2007-26262 A Summary of the Invention [Problem to be solved by the invention]

[0004] The production capacity of equol produced from isoflavones depends on the intestinal environment and varies greatly from person to person. However, equol and isoflavone supplements generally have a set intake amount listed, making it difficult to suggest an appropriate amount for each individual user. The present disclosure aims to provide a technology for improving the equol intake of each individual user. [Means for solving the problem]

[0005] The present disclosure can be realized in the following aspects. (Aspect 1) Obtaining an index value representing the level of equol production ability of the target user and information representing the condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of the other user whose information representing equol production ability and condition is similar to that of the target user, using information of the other user including an index value representing the degree of equol production ability of the other user, information representing the state of the other user, and information representing the amount of equol and / or isoflavone intake of the other user, which is stored in advance in a storage device; outputting the determined recommended amount; The recommended output system includes one or more computers running the (Aspect 2) The index value is a value corresponding to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. A recommended amount output system according to embodiment 1. (Aspect 3) The information representing the condition is information representing the degree to which the user has answered about symptoms that may appear due to menopausal disorder. 3. The recommended amount output system according to claim 1 or 2. (Aspect 4) The information indicating the state includes at least one of the user's electrocardiogram, heart rate, blood oxygen concentration, an index indicating the quality of sleep, body temperature, sweat amount, and sweat components. A recommended amount output system according to any one of aspects 1 to 3. (Aspect 5) The information of the other user includes information representing the state of the other user at a plurality of time points and information representing the intake amount of equol and / or isoflavone of the other user, The determination process uses information of the other user, whose condition at a second time point after the first time point has improved compared to information representing the condition of the other user at the first time point, to determine a recommended amount of equol and / or isoflavones to be ingested by the target user based on the intake amount of equol and / or isoflavones of the other user at the first time point, whose equol production ability and information representing the condition at the first time point are similar to those of the target user. A recommended amount output system according to any one of aspects 1 to 4. (Aspect 6) If the target user takes the output recommended amount of the equol and / or isoflavone for a predetermined period of time, and if the information representing the condition of the target user is not determined to have improved based on a predetermined criterion, the recommended amount is corrected in the determination process. A recommended amount output system according to any one of aspects 1 to 5. (Aspect 7) Obtaining information representing the level of equol production ability of a target user and information representing a condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of other users whose information representing equol production ability and condition is similar to that of the target user, using information of other users including information representing the level of equol production ability of the other users, information representing the condition of the other users, and information representing the equol and / or isoflavone intake of the other users, which is stored in advance in a storage device; outputting the determined recommended amount; The recommended amount of output is 1 or more computers running the method. (Aspect 8) The index value is a value corresponding to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. A method for outputting a recommended amount according to aspect 7. (Aspect 9) Obtaining information representing the level of equol production ability of a target user and information representing a condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of other users whose information representing equol production ability and condition is similar to that of the target user, using information of other users including information representing the level of equol production ability of the other users, information representing the condition of the other users, and information representing the equol and / or isoflavone intake of the other users, which is stored in advance in a storage device; outputting the determined recommended amount; A program for executing the above on one or more computers. (Aspect 10) The index value is a value corresponding to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. A program according to embodiment 9.

[0006] The content of the means for solving the problem may be a device such as a computer or multiple devices. The present invention can be provided as a system including the above, a method executed by one or more computers, or a program executed by one or more computers. A recording medium for storing the program may be provided. Effect of the Invention

[0007] The disclosed technology can provide a technique for improving an individual user's equol intake. [Brief description of the drawings]

[0008] [Figure 1] FIG. 1 is a diagram illustrating an example of a system according to an embodiment. [Diagram 2] FIG. 2 is a diagram illustrating the relationship between the intake amount of isoflavone and the amount of equol produced. [Diagram 3] FIG. 3 is a process flow diagram illustrating the learning process according to the embodiment. [Figure 4] FIG. 4 is a process flow diagram for explaining the details of data collection and pre-processing. [Diagram 5] FIG. 5 is a diagram illustrating an example of data stored in a storage device. [Figure 6] FIG. 6 is a process flow diagram illustrating an example of the recommended amount output process. [Figure 7] FIG. 7 is a diagram showing an example of data stored in a storage device in the first modified example. [Figure 8] FIG. 8 is a diagram showing an example of data stored in a storage device in the second modified example. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] Hereinafter, embodiments will be described with reference to the drawings.

[0010] <Embodiment 1> FIG. 1 is a diagram showing an example of a system according to the present embodiment. The system 100 includes a server 1 and terminals 2 (2A, 2B, 2C). The server 1 learns the relationship between the user's equol production ability, information on the user's condition such as subjective symptoms related to menopausal disorder, and the intake amount of at least one of isoflavones and equol, and performs a process of recommending ingredients to be ingested to the user (i.e., at least one of isoflavones and equol) based on the learning result. The learning process and the recommendation process may be performed by different devices. The terminal 2 is, for example, a computer owned by a user who is to receive a recommendation of ingredients to be ingested. The server 1 collects information on the user's condition, such as the amount of equol in the user's excrement (hereinafter referred to as "equol discharge amount"), via the terminal 2, and outputs the recommended amount of ingredients to be ingested to the terminal 2. The terminal 2 may include, for example, a computer of a testing institution that measures the equol discharge amount of the user. The server 1 and the terminal 2 are connected to each other via a network 3 so as to be able to communicate with each other. The network 3 includes, for example, an IP (Internet Protocol) network, and the like, connected to the network 3, The devices can communicate based on a predetermined communication protocol. A part of the network 3 may be a telephone network (fixed telephone network or mobile communication network), an ad hoc network, an intranet, a VPN (Virtual Private Network), a LAN (Local Area Network), a Wireless LAN, a WAN (Wide Area Network), or the Internet.

[0011] In addition, isoflavones in the present disclosure include flavonoids that have an isoflavone (3-phenylchromone) as a basic skeleton, which are converted to equol in the intestines of individuals with equol-producing ability. Examples of such flavonoids include daidzein. Daidzein is converted to equol in the intestines of individuals with equol-producing ability. In addition, isoflavones in the present disclosure include genistein, guanidine, and glycerol. It may further contain rishitein, etc. Furthermore, examples of isoflavones in the present disclosure include soybean isoflavones, kudzu isoflavones, etc.

[0012] The server 1 is a computer, and includes a processor 11, a storage device 12, and a communication interface (IF) 13. The processor 11 is a CPU (Central Processing Unit). ), which executes programs to perform each process according to this embodiment. The storage device 12 is a main storage device such as a random access memory (RAM) or a read only memory (ROM), and an auxiliary storage device (secondary storage device) such as a hard disk drive (HDD), a solid state drive (SSD), or a flash memory. The main storage device temporarily stores programs read by the processor 11 and secures a working area for the processor 11. The auxiliary storage device stores programs executed by the processor 11 and other data. The communication IF 13 is a network module for communicating via the network 3, and transmits and receives data based on a predetermined protocol.

[0013] Terminal 2 is a tablet, smartphone, PC (Personal Computer), or wearable device. The terminal 2 is a computer such as a terminal. The terminal 2 includes a processor, a storage device, a communication IF, and an input / output interface (IF) for inputting and outputting information to and from a user.

[0014] In this embodiment, the equol production capacity of each user is measured, and the components and recommended amount to be ingested are determined according to the production capacity. Specifically, each user refrains from ingesting isoflavones through their diet for a predetermined period of time, and measures the amount of equol discharged after ingesting a predetermined amount of isoflavone-containing supplements. In addition, the intake of isoflavones through diet includes ingesting isoflavone-containing foods as dishes. A supplement is a product containing a predetermined component, and includes those processed into dosage forms such as tablets, capsules, granules, and powders, as well as health functional foods and other health foods in which the content of a predetermined component is fixed. Equol is produced from isoflavones by intestinal bacteria (equol-producing bacteria). That is, differences occur in equol production capacity depending on the intestinal environment of each individual. The level of equol production capacity can be known based on at least one of the amount of equol discharge, which can be measured by at least one of a urine test and a stool test, and the blood concentration of equol, which can be measured by a blood test. The equol production capacity may be inferred by sweat measurement (a test on the amount of sweat or the components of sweat, or a combination thereof) or changes in heart rate. FIG. 2 is a diagram for explaining the relationship between the intake amount of isoflavone and the amount of equol production. In the graph of FIG. 2, the horizontal axis indicates the intake amount of isoflavone, and the vertical axis indicates the amount of equol production. In the graph of FIG. 2, a schematic example of the amount of equol production when a predetermined amount of isoflavone-containing supplement is taken is plotted with circles. The higher the equol production capacity of a user, the higher the amount of equol production, and the lower the production capacity of a user, the lower the amount of equol production. In addition, the amount of equol production increases in proportion to the amount of isoflavone intake. In addition, it is understood that the amount of equol production is expressed by the amount of equol excreted in the user's urine or feces. By measuring the amount of equol excreted in advance, the degree of equol production capacity of each individual user can be grasped. Generally, after ingesting a food containing isoflavones, equol appears in the blood approximately 8 hours later, reaches its maximum concentration within 12 to 24 hours, and is excreted from the body within approximately 72 hours.Therefore, it is preferable that the blood test, urine test, and stool test are each performed after a predetermined time has elapsed since the user took the supplement, etc., and within a predetermined time longer than that. In other words, the period during which the blood concentration and excretion amount of equol should be measured can be appropriately determined based on, for example, the timing when the blood concentration is expected to be maximum.

[0015] In addition, in this embodiment, information on the user's condition, such as the degree of symptoms that may appear due to menopausal disorders, and information on the components (i.e., at least some of isoflavones and equol) that the user is taking in through at least one of foods and supplements are collected from a plurality of users. Information on the user's condition and the amount of intake is collected, and a recommendation process is performed based on the components and the amount of intake taken by users with similar conditions. The above-mentioned components can generally be taken in at least one of isoflavone-containing foods, isoflavone-containing supplements, and equol-containing supplements. The information on the user's condition includes, for example, information expressing the degree of symptoms in a graded evaluation value for at least one of symptoms that may appear due to menopausal disorders, such as stiff shoulders, fatigue, headache, hot flashes, back pain, sweating, insomnia, irritability, skin itching, palpitations, depression, dizziness, stomach upset, vaginal dryness, etc. Information on the user's condition, the components being taken, and the amount of intake may be collected from the user as, for example, responses to a questionnaire. In addition, the recommendation process performs, for example, user-based collaborative filtering. That is, the components and the amount of intake taken by users with similar tendencies in symptoms to the target user are identified, and the components and the amount of intake recommended to the target user are determined based on the identified components and amounts of intake. The method of recommendation processing is not particularly limited, and the relationship between the tendency of symptoms and the ingested ingredients and the intake amount may be modeled in advance to perform model-based collaborative filtering, or the relationship between the tendency of symptoms as explanatory variables and the ingested ingredients and the intake amount as objective variables may be modeled by deep learning, and recommendation processing may be performed based on a model that determines the recommended amount based on the symptoms of the target user. If the equol production ability of the user who answers the questionnaire is known, the intake amount of isoflavone-containing foods or the intake amount of isoflavone-containing supplements may be converted to the equol production amount, and the objective variable may be unified to the intake amount of equol. In addition, rules based on the relationship between the tendency of symptoms and the intake amount may be created in advance, and rule-based recommendation processing may be performed.

[0016] In addition, it is preferable to perform recommendation processing based on the intake of isoflavones, etc., of users with similar equol production ability. That is, equol production ability varies from person to person, and the preferred intake amount of isoflavones, etc. varies depending on production ability. Therefore, in this embodiment, recommendation processing is performed for each user with similar equol production ability based on the similarity of symptoms.

[0017] <Learning process> Fig. 3 is a process flow diagram for explaining the learning process according to the embodiment. In the learning process, the server 1 collects an index value representing the equol production ability of each user and information related to the user's condition, and performs preprocessing (Fig. 3: S1). Fig. 4 is a process flow diagram for explaining the details of data collection and preprocessing. The processor 11 of the server 1 acquires one piece of unprocessed data (Fig. 4: S11).

[0018] FIG. 5 is a diagram showing an example of data stored in the storage device 12. The table shown in this embodiment is an example of a database, and information may be properly normalized and stored in multiple tables, or may be denormalized and stored collectively in one table. The table in FIG. 5 includes attributes of "user ID", "production capacity", "condition", and "intake". Identification information for uniquely identifying a user is registered in the "user ID" field. An index value representing the degree of equol production capacity of the user is registered in the "production capacity" field. The index value may be a value corresponding to a measured value of equol discharge measured in advance by the user, or may be the measured value itself. In addition, the index value may be calculated, for example, as a ratio of equol discharge (mg) to isoflavone intake (mg). The "condition" includes attributes representing symptoms such as "stiff shoulders", "easily tired", ..., "lower back pain", "sweating", and "insomnia". In addition, in each "condition" field, a value answered by the user himself / herself using a five-level evaluation ranging from "1" indicating a bad condition to "5" indicating a good condition is registered. The "intake" field registers the amount of isoflavones the user ingests on a daily basis, or the converted value of the amount of equol produced from isoflavones. For example, if a user responds to the questionnaire that they consume one pack of natto and one cup (200g) of soy milk per day, the value converted into the daily isoflavone intake based on a predetermined conversion formula between food and isoflavone is registered in the "intake" field. 4, the processor 11 acquires data corresponding to one record shown in FIG.

[0019] After S11, processor 11 judges whether the user indicated by the acquired data has equol production ability (FIG. 4: S12). In this step, it is judged whether the index value of production ability in the acquired data is equal to or greater than a predetermined threshold. It is assumed that a predetermined value close to 0, for example, is stored as the threshold for judging the presence or absence of production ability. If the index value of production ability is less than the threshold, it is judged that there is no production ability (S11: NO), and processor 11 classifies the data into first learning data (also called learning data 1) (FIG. 4: S13). For example, user 1 in FIG. 5 has a production ability of 0, and the record is classified into learning data 1.

[0020] On the other hand, if the productivity index value is equal to or greater than the threshold value, it is determined that the user has productivity (S11: YES), and the processor 11 determines whether the user's productivity is equal to or greater than a predetermined standard (FIG. 4: S14). It is assumed that a second threshold value greater than the threshold value of S12 is set in advance as the predetermined standard. For example, the predetermined standard is set to 0.2. If the productivity index value does not meet the predetermined standard (S14: NO), the processor 11 classifies the data into second learning data (also called learning data 2) (FIG. 4: S15). User 2 in FIG. 5 has a productivity of 0.1, which is lower than the standard, and the record is classified into learning data 2.

[0021] On the other hand, if the productivity index value is equal to or greater than the predetermined standard (S14: YES), the processor 11 classifies the data into third learning data (also called learning data 3) (FIG. 4: S16). User 3 in FIG. 5 has a productivity of 0.3, which is equal to or greater than the standard, and the record is classified into learning data 3.

[0022] Then, after S13, S15, or S16, the processor 11 determines whether to end the pre-processing (FIG. 4: S17). For example, when all the records shown in FIG. 5 have been processed, the processor 11 determines to end the processing (S17: YES) and returns to the processing in FIG. 3. On the other hand, when there are unprocessed records, the processor 11 determines not to end the processing (S17: NO) and returns to S11 to repeat the processing in FIG. 4.

[0023] By carrying out the above preprocessing, the learning data can be classified into groups of users with similar productivity. Note that the number of groups for classification is not limited to three.

[0024] After S1 in Fig. 3, the processor 11 constructs a model for each classified data (Fig. 3: S2). In this step, a model is created when performing model-based collaborative filtering or recommendation processing by deep learning. Note that, for example, when performing user-based collaborative filtering, S2 may be omitted.

[0025] <Recommended output processing> 6 is a process flow diagram showing an example of a recommended amount output process. The recommended amount output process is started, for example, periodically or when a request is received from the terminal 2 by a user operation.

[0026] The processor 11 of the server 1 acquires the productivity index value and information on the user's condition (e.g., information on symptoms) for the user for whom the recommended amount is to be proposed (FIG. 6: S21). These pieces of information may be received from the terminal 2, for example, as a response to a questionnaire for the user.

[0027] After S21, the processor 11 judges whether the target user has a productivity equal to or higher than a predetermined standard value (FIG. 6: S22). In this step, the same judgment as in S12 in FIG. 4 is performed. That is, processor 11 determines whether the index value stored in association with the identification information of the target user is equal to or greater than a predetermined threshold. If the index value is less than the threshold, it is determined that the user does not have the ability to produce equol (S22: NO), and information recommending an equol-containing supplement equivalent to a predetermined target amount is transmitted to user terminal 2 (FIG. 6: S23). For users whose equol production ability is lower than the standard, the process of S23 is repeated in the recommended amount output process.

[0028] On the other hand, if the index value is equal to or greater than the threshold, it is determined that the user has equol production ability (S22: YES), and the processor 11 determines the recommended amount for the target user based on the intake amounts of other users who have similar information on the user's condition (FIG. 6: S24). In this step, the components and recommended amounts to be ingested by the target user are determined using, for example, the model created in S2 of FIG. 3. That is, the recommended amounts of the components to be ingested by the target user are determined based on the components and intake amounts ingested by other users who have similar information on equol production ability and condition to the target user. Note that, when performing user-based collaborative filtering, a trained model is not used, and other users who have similar information on equol production ability and condition to the target user are extracted from a table such as that shown in FIG. 5, and the components to be ingested and the recommended amounts are determined based on the components and intake amounts ingested by the extracted users. Note that, when multiple users are extracted, the recommended amounts may be determined based on statistics such as the average intake amounts of the extracted users.

[0029] After S24, the processor 11 suggests at least one of isoflavone-containing foods, isoflavone-containing supplements, and equol-containing supplements to the user (FIG. 6: S25). The recommended intake modes include at least one of (1) equol-containing supplements only, (2) isoflavone-containing supplements only, (3) isoflavone-containing foods only, (4) equol-containing supplements and isoflavone-containing supplements, (5) equol-containing supplements and isoflavone-containing foods, (6) isoflavone-containing supplements and isoflavone-containing foods, and (7) equol-containing supplements, isoflavone-containing supplements, and isoflavone-containing foods. The processor 11 transmits information proposing the components to be ingested and the recommended amounts determined in S24 to the user's terminal 2 via the network IF 13 and the network 3.

[0030] <Effects> According to the above embodiment, it is possible to suggest an intake amount for each individual user based on the similarity of production capacity and condition with other users, thereby making it possible to improve the equol intake of each individual user.

[0031] <Variation 1> Next, the first modification will be described with a focus on differences from the above-mentioned embodiment. In this modification, a user carries a terminal 2, which is a wearable terminal such as a smart watch or an activity meter, and data obtained from the wearable terminal is used as information representing the user's condition. The wearable terminal is equipped with a biosensor and outputs vital data including at least one of the user's electrocardiogram, heart rate, blood oxygen concentration, information on the quality of sleep, body temperature (skin temperature), sweat amount, sweat components, etc. It is preferable that the vital data is data that shows the effects of menopausal disorders that can be expected to be improved by equol. In addition, it is preferable that the conditions under which the user measures the vital data, such as after resting for a predetermined period of time, be unified as much as possible.

[0032] The vital data may be the data obtained directly from the wearable device, or may be input by the user as a five-level evaluation of physical condition. FIG. 7 is a diagram showing an example of data stored in the storage device 12 in this modification. The table in FIG. 7 shows "condition" as "electrocardiogram," "heart rate," ..., "sleep," etc. The attributes include "quality," "body temperature," and "amount of sweat." In addition, in each "condition" field, a value input by the user using a five-point scale ranging from "1" indicating a poor condition to "5" indicating a good condition, or a value automatically converted from vital data is registered. In addition, in each "condition" field, vital data itself may be registered.

[0033] Then, instead of or in addition to the information on the severity of symptoms collected by questionnaires or the like in the above-mentioned embodiment, the vital data according to the modified example is used to determine the ingredients and recommended amounts to be ingested by the target user based on the ingredients and intake amounts taken by other users who have similar information on equol production capacity and condition to the target user. Even in this way, it is possible to suggest ingredients and intake amounts to be ingested for each individual user based on the similarity of production capacity and condition with other users. Note that if the vital data itself is used, the hassle of answering questionnaires can be reduced for the user.

[0034] <Variation 2> Next, a second modified example will be described focusing on the differences from the above-mentioned embodiment. In this modified example, the conditions and intake amounts of other users at multiple points in time are stored in the storage device 12, and a recommendation process is performed for a user whose condition has improved based on the ingredients and intake amounts that the user had taken before the improvement.

[0035] FIG. 8 is a diagram showing an example of data stored in the storage device 12 in this modified example. The state of user 4 on May 25 is generally higher than the state of user 4 on March 20. On the other hand, it cannot be said that the state of user 5 on April 10 and the state of user 5 on August 12 have improved as a whole. Whether the evaluation has improved or not can be determined based on any predetermined judgment criterion. The processor 11 of the server 1 can determine whether the evaluation has improved or not based on, for example, the average increase or decrease in the evaluation of each state, or can further determine by setting a condition such as that there is no value that has decreased by more than a predetermined criterion. In this modified example, a user whose state has improved, such as user 4, performs a recommendation process based on the ingredients and intake amounts that he or she ingested before the improvement.

[0036] That is, in the process of Fig. 4, not only the magnitude of the productivity but also the data of the user whose condition is judged to have improved is classified as learning data. Also, in the process of Fig. 6, the components to be ingested by the target user and the recommended amounts are determined based on the components and intake amounts ingested by other users whose condition is judged to have improved before the improvement.

[0037] According to this modification, the amount of intake can be suggested based on the similarity of productivity and condition with users who have a track record of improving their condition. Therefore, it becomes possible to suggest ingredients and recommended amounts that are more likely to improve. In addition, the first and second modifications may be combined to suggest the amount of intake based on the similarity of productivity and condition with users whose vital data evaluation has improved.

[0038] <Variation 3> If the condition of the target user does not improve even after taking the recommended amount of the component for a predetermined period of time, the recommended amount proposed in S25 of Fig. 6 may be changed by modifying the model created in S2 of Fig. 3 or adjusting a coefficient for correcting the determined recommended amount. For example, when a correction coefficient is used, the determined recommended amount is further multiplied by the coefficient in S25 of Fig. 6 to calculate the recommended amount to be output. Also, for example, after increasing or decreasing the recommended amount, the recommended amount may be repeatedly changed depending on whether the condition has improved after a predetermined period of time.

[0039] <Other> Each configuration and their combinations in each embodiment are merely examples, and addition, omission, substitution, and other modifications of the configurations are possible as appropriate within the scope of the present disclosure. The present disclosure is not limited by the embodiments, but is limited only by the scope of the claims. In addition, each aspect disclosed in this specification can be combined with any other feature disclosed in this specification.

[0040] At least a part of the functions of the server 1 may be distributed among a plurality of devices, or the same functions may be provided in parallel by a plurality of devices.

[0041] The present disclosure also includes a method and a computer program for executing the above-mentioned processes, and a computer-readable recording medium having the program recorded thereon. The recording medium having the program recorded thereon enables the above-mentioned processes by causing a computer to execute the program.

[0042] Here, a computer-readable recording medium refers to a recording medium that stores information such as data and programs through electrical, magnetic, optical, mechanical, or chemical action and can be read by a computer. Among such recording media, those that can be removed from a computer include flexible disks, magneto-optical disks, optical disks, magnetic tapes, memory cards, etc. Furthermore, recording media that are fixed to a computer include HDDs, SSDs (Solid State Drives), ROMs, etc. [Explanation of symbols]

[0043] 100: System 1: Server, 11: Processor, 12: Storage device, 13: Communication interface 2: Terminal 3: Network

Claims

1. Obtaining an index value representing the level of equol production ability of the target user and information representing the condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of the other user whose information representing equol production ability and condition is similar to that of the target user, using information of the other user including an index value representing the degree of equol production ability of the other user, information representing the state of the other user, and information representing the equol and / or isoflavone intake of the other user, which is stored in advance in a storage device; outputting the determined recommended amount; A recommendation output system comprising one or more computers running the above-mentioned.

2. The index value corresponds to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. The recommended amount output system according to claim 1.

3. The information representing the condition is information representing the degree to which the user has answered about symptoms that may appear due to menopausal disorder.

3. The recommended amount output system according to claim 1 or 2.

4. The information indicating the state includes at least one of the user's electrocardiogram, heart rate, blood oxygen concentration, an index indicating the quality of sleep, body temperature, sweat amount, and sweat components.

3. The recommended amount output system according to claim 1 or 2.

5. The information of the other user includes information representing the state of the other user at a plurality of time points and information representing the intake amount of equol and / or isoflavone of the other user, The determination process uses information of the other user in which information representing the other user's condition at a first time point is improved compared to information representing the other user's condition at the first time point, to determine whether the other user's equol production ability and information representing the condition at the first time point of the target user are similar to those of the target user. and / or based on the amount of isoflavones consumed, determine a recommended amount of equol and / or isoflavones that the target user should consume.

3. The recommended amount output system according to claim 1 or 2.

6. If the target user takes the output recommended amount of the equol and / or isoflavone for a predetermined period of time, but the information representing the condition of the target user is not determined to have improved based on a predetermined criterion, the recommended amount is corrected in the determination process. The recommended amount output system according to claim 1 or 2.

7. Obtaining an index value representing the level of equol production ability of the target user and information representing the condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of the other user whose information representing equol production ability and condition is similar to that of the target user, using information of other users including information representing the other user's level of equol production ability, information representing the other user's condition, and information representing the other user's intake of equol and / or isoflavones, which is stored in advance in a storage device; outputting the determined recommended amount; The recommended output method is to run one or more computers.

8. The index value is a value corresponding to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. The method for outputting a recommended amount according to claim 7.

9. Obtaining an index value representing the level of equol production ability of the target user and information representing the condition of the target user; a determination process for determining a recommended amount of equol and / or isoflavones to be consumed by the target user based on the equol and / or isoflavone intake of the other user whose information representing equol production ability and condition is similar to that of the target user, using information of other users including information representing the other user's level of equol production ability, information representing the other user's condition, and information representing the other user's intake of equol and / or isoflavones, which is stored in advance in a storage device; outputting the determined recommended amount; A program for causing one or more computers to execute the above.

10. The index value is a value corresponding to the amount of equol excreted or blood concentration after a predetermined time has elapsed since the user refrained from ingesting isoflavones through diet for a predetermined period of time or more and ingested a predetermined amount of an isoflavone-containing supplement. The program according to claim 9.

Citation Information

Patent Citations

  • Nutrients management system, and commodity proposition server and portable terminal for the same

    JP2007026262A

  • Method for providing meal menu and program

    JP2014021723A

  • Health care device, health care system, and health care method

    JP2018049393A

  • Method for managing menu, system, program, recording medium, server and terminal

    JP2021043721A

  • Information provision method for predicting health condition of consumer and supporting health maintenance and improvement

    WO2023017857A1